SG10201913618WA - Use of stem cells to reduce leukocyte extravasation - Google Patents
Use of stem cells to reduce leukocyte extravasationInfo
- Publication number
- SG10201913618WA SG10201913618WA SG10201913618WA SG10201913618WA SG10201913618WA SG 10201913618W A SG10201913618W A SG 10201913618WA SG 10201913618W A SG10201913618W A SG 10201913618WA SG 10201913618W A SG10201913618W A SG 10201913618WA SG 10201913618W A SG10201913618W A SG 10201913618WA
- Authority
- SG
- Singapore
- Prior art keywords
- stem cells
- leukocyte extravasation
- reduce leukocyte
- reduce
- extravasation
- Prior art date
Links
- 206010015866 Extravasation Diseases 0.000 title 1
- 230000036251 extravasation Effects 0.000 title 1
- 210000000265 leukocyte Anatomy 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/03—Coculture with; Conditioned medium produced by non-embryonic pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22731109P | 2009-07-21 | 2009-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201913618WA true SG10201913618WA (en) | 2020-03-30 |
Family
ID=43497498
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012004164A SG178065A1 (en) | 2009-07-21 | 2010-07-21 | Use of stem cells to reduce leukocyte extravasation |
SG10201404281YA SG10201404281YA (en) | 2009-07-21 | 2010-07-21 | Use of stem cells to reduce leukocyte extravasation |
SG10201913618WA SG10201913618WA (en) | 2009-07-21 | 2010-07-21 | Use of stem cells to reduce leukocyte extravasation |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012004164A SG178065A1 (en) | 2009-07-21 | 2010-07-21 | Use of stem cells to reduce leukocyte extravasation |
SG10201404281YA SG10201404281YA (en) | 2009-07-21 | 2010-07-21 | Use of stem cells to reduce leukocyte extravasation |
Country Status (9)
Country | Link |
---|---|
US (2) | US20110020292A1 (en) |
EP (1) | EP2456860B1 (en) |
AU (1) | AU2010276264B2 (en) |
CA (1) | CA2768573C (en) |
DK (1) | DK2456860T3 (en) |
ES (1) | ES2690199T3 (en) |
IL (1) | IL217643B (en) |
SG (3) | SG178065A1 (en) |
WO (1) | WO2011011477A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
CN101978047A (en) | 2008-01-18 | 2011-02-16 | 明尼苏达大学董事会 | Stem cell aggregates and methods for making and using |
SG10201913920PA (en) | 2010-05-12 | 2020-03-30 | Abt Holding Co | Modulation of splenocytes in cell therapy |
EP3795159A1 (en) | 2013-04-12 | 2021-03-24 | Houston Methodist Hospital | Improving organs for transplantation |
KR20180102661A (en) | 2016-01-21 | 2018-09-17 | 에이비티 홀딩 컴퍼니 | Stem cells for wound healing |
KR102548560B1 (en) * | 2016-05-20 | 2023-06-29 | 로버트 색스테인 | Glycoengineering of e-selectin ligands |
JP2023523583A (en) * | 2020-04-23 | 2023-06-06 | エービーティー ホールディング カンパニー | Treatment of virus-induced acute respiratory distress syndrome |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
AU650616B2 (en) | 1988-09-21 | 1994-06-30 | Animal Biotechnology Cambridge Limited | Derivation of pluripotential embryonic cell lines from domestic animals |
US7037721B1 (en) | 1990-01-29 | 2006-05-02 | Hy-Gene Biomedical, Inc. | Protein-free defined media for the growth of normal human keratinocytes |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5811094A (en) | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
GB2254289B (en) | 1991-04-05 | 1995-03-22 | Gerber Garment Technology Inc | Readily transferrable adherent tape and methods of use and making |
AU2882992A (en) | 1991-11-06 | 1993-06-07 | Arthur A. Axelrad | Cell culture medium |
US5340740A (en) | 1992-05-15 | 1994-08-23 | North Carolina State University | Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process |
WO1994000484A1 (en) * | 1992-06-22 | 1994-01-06 | Young Henry E | Scar inhibitory factor and use thereof |
US5453357A (en) | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
US7153684B1 (en) | 1992-10-08 | 2006-12-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
US5766951A (en) | 1992-11-12 | 1998-06-16 | Quality Biological, Inc. | Serum-free medium supporting growth and proliferation of normal bone marrow cells |
US6037174A (en) | 1993-08-23 | 2000-03-14 | Nexell Therapeutics, Inc. | Preparation of serum-free suspensions of human hematopoietic cells or precursor cells |
US5409813A (en) | 1993-09-30 | 1995-04-25 | Systemix, Inc. | Method for mammalian cell separation from a mixture of cell populations |
US6432711B1 (en) | 1993-11-03 | 2002-08-13 | Diacrin, Inc. | Embryonic stem cells capable of differentiating into desired cell lines |
FR2726003B1 (en) | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | CULTURE MEDIUM OF AVIAN TOTIPOTENT EMBRYONIC CELLS, METHOD FOR CULTURING THESE CELLS, AND AVIAN TOTIPOTENT EMBRYONIC CELLS |
US5914268A (en) | 1994-11-21 | 1999-06-22 | National Jewish Center For Immunology & Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5874301A (en) | 1994-11-21 | 1999-02-23 | National Jewish Center For Immunology And Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
GB9502022D0 (en) * | 1995-02-02 | 1995-03-22 | Abuljadayel Ilham M S | A method for preparing lymphohaematopoietic progenitor cells |
US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
US6653134B2 (en) * | 1995-03-28 | 2003-11-25 | Cp Hahnemann University | Isolated stromal cells for use in the treatment of diseases of the central nervous system |
US5837670A (en) | 1995-04-18 | 1998-11-17 | Hartshorn; Richard Timothy | Detergent compositions having suds suppressing properties |
US5908782A (en) | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
EP0888377B1 (en) * | 1996-03-08 | 2007-12-12 | The Regents Of The University Of Michigan | MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII) |
US6190910B1 (en) | 1996-05-21 | 2001-02-20 | The Institute Of Physical And Chemical Research | Mouse embryonic stem cell lines |
US5753506A (en) | 1996-05-23 | 1998-05-19 | Cns Stem Cell Technology, Inc. | Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals |
US5827740A (en) | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
US5945337A (en) | 1996-10-18 | 1999-08-31 | Quality Biological, Inc. | Method for culturing CD34+ cells in a serum-free medium |
US6361996B1 (en) | 1997-05-07 | 2002-03-26 | University Of Utah Research Foundation | Neuroepithelial stem cells and glial-restricted intermediate precursors |
AU7984498A (en) | 1997-06-25 | 1999-01-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Serum-free cell growth medium |
WO1999001159A1 (en) | 1997-07-04 | 1999-01-14 | University Of Utah Research Foundation | Lineage-restricted neuronal precursors |
US5968829A (en) | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
US6875607B1 (en) | 1998-11-09 | 2005-04-05 | Es Cell International Pte Ltd | Embryonic stem cells |
WO2000027996A1 (en) | 1998-11-09 | 2000-05-18 | Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate | Serum free medium for chondrocyte-like cells |
US20050153442A1 (en) | 1999-03-10 | 2005-07-14 | Adam Katz | Adipose-derived stem cells and lattices |
US6777231B1 (en) * | 1999-03-10 | 2004-08-17 | The Regents Of The University Of California | Adipose-derived stem cells and lattices |
US20050169896A1 (en) * | 1999-05-14 | 2005-08-04 | Henry Ford Health System | Bone marrow transplantation for treatment of stroke |
NZ517002A (en) * | 1999-08-05 | 2004-06-25 | Mcl Llc | Multipotent adult stem cells and methods for isolation |
US7015037B1 (en) * | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US8147824B2 (en) * | 1999-08-05 | 2012-04-03 | Athersys, Inc. | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
AU7611500A (en) * | 1999-09-24 | 2001-04-24 | Abt Holding Company | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
DE60041821D1 (en) * | 1999-09-24 | 2009-04-30 | Cybios Llc | PLURIPOTENT EMBRYONAL STEM CELL-SIMILAR CELLS, COMPOSITIONS, AND ITS CONDITIONS |
US20030161817A1 (en) * | 2001-03-28 | 2003-08-28 | Young Henry E. | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
EP1257282A4 (en) * | 1999-12-06 | 2003-05-02 | Gen Hospital Corp | Pancreatic stem cells and their use in transplantation |
AU3869501A (en) * | 2000-02-26 | 2001-09-03 | Artecel Sciences Inc | Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
US7582292B2 (en) * | 2000-02-26 | 2009-09-01 | Artecel, Inc. | Adipose tissue derived stromal cells for the treatment of neurological disorders |
EP2298867A3 (en) | 2000-06-20 | 2013-01-16 | ES Cell International Pte Ltd. | Method of controlling differentiation of embryonic stem (ES) cells by culturing ES cells in the presence of bmp-2 pathway antagonists |
AU2001284695A1 (en) * | 2000-07-31 | 2002-02-13 | New York Medical College | Methods and compositions for the repair and/or regeneration of damaged myocardium |
AU2001296705A1 (en) * | 2000-10-06 | 2002-04-15 | The Regents Of The University Of California | Blocking inflammation by inhibiting sialylation |
US7560280B2 (en) | 2000-11-03 | 2009-07-14 | Kourion Therapeutics Gmbh | Human cord blood derived unrestricted somatic stem cells (USSC) |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
EP2305795B1 (en) * | 2000-12-06 | 2019-07-03 | Celularity, Inc. | Method of collecting placental stem cells |
EP1491093B1 (en) | 2001-02-14 | 2013-07-31 | ABT Holding Company | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
EP2336300B1 (en) * | 2001-02-14 | 2015-07-08 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
US7056738B2 (en) * | 2001-03-23 | 2006-06-06 | Tulane University | Early stage multipotential stem cells in colonies of bone marrow stromal cells |
KR100449141B1 (en) * | 2001-04-19 | 2004-09-21 | (주)라이프코드 | Method for differentiating a mesenchymal stem cell into neural cells |
US20030003090A1 (en) * | 2001-05-31 | 2003-01-02 | Prockop Darwin J. | Directed in vitro differentiation of marrow stromal cells into neural cell progenitors |
BR0212098A (en) | 2001-08-23 | 2004-08-03 | Reliance Life Sciences Pvt Ltd | Internal cell mass isolation method for the establishment of human embryonic stem cell lines (hesc) |
US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
US6703279B2 (en) | 2002-01-04 | 2004-03-09 | Promos Technologies, Inc. | Semiconductor device having contact of Si-Ge combined with cobalt silicide |
JP2005515777A (en) | 2002-01-25 | 2005-06-02 | ジェンザイム・コーポレーション | Serum-free medium for chondrocytes and use thereof |
US7145057B2 (en) | 2002-02-01 | 2006-12-05 | Origen Therapeutics, Inc. | Chimeric bird from embryonic stem cells |
WO2003080197A1 (en) | 2002-03-20 | 2003-10-02 | Sara Griffin | Sports training device |
GB0221481D0 (en) | 2002-09-16 | 2002-10-23 | Richards John M | Grip for hand held instruments |
US7785601B2 (en) * | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
US20040235165A1 (en) * | 2003-05-19 | 2004-11-25 | Darwin Prockop | In vitro differentiation of adult stem cells |
WO2005041944A2 (en) * | 2003-06-27 | 2005-05-12 | Schepens Eye Research Institute | Methods and compositions for promoting axon regeneration and cell replacement therapy |
MXPA06000974A (en) * | 2003-07-25 | 2006-08-31 | Amgen Inc | Antagonists and agonists of ldcam and methods of use. |
EP1660644A1 (en) * | 2003-08-29 | 2006-05-31 | Regents Of The University Of Minnesota | Kidney derived stem cells and methods for their isolation, differentiation and use |
US20070225251A1 (en) * | 2003-09-08 | 2007-09-27 | Michal Eisenbach-Schwartz | Method for Treating or Inhibiting the Effects of Injuries or Diseases that Result in Neuronal Degeneration |
US7622108B2 (en) * | 2004-04-23 | 2009-11-24 | Bioe, Inc. | Multi-lineage progenitor cells |
US20100008890A1 (en) * | 2006-01-23 | 2010-01-14 | Athersys, Inc. | MAPC Therapeutics Without Adjunctive Immunosuppressive Treatment |
WO2009043159A1 (en) * | 2007-10-01 | 2009-04-09 | The Hospital For Sick Children | Neural tumor stem cells and methods of use thereof |
US20090130092A1 (en) * | 2007-10-30 | 2009-05-21 | Pinsky David J | Nucleotide phosphate dissipation as a treatment for vascular disorders |
-
2010
- 2010-07-21 SG SG2012004164A patent/SG178065A1/en unknown
- 2010-07-21 DK DK10802822.6T patent/DK2456860T3/en active
- 2010-07-21 SG SG10201404281YA patent/SG10201404281YA/en unknown
- 2010-07-21 ES ES10802822.6T patent/ES2690199T3/en active Active
- 2010-07-21 WO PCT/US2010/042690 patent/WO2011011477A1/en active Application Filing
- 2010-07-21 CA CA2768573A patent/CA2768573C/en active Active
- 2010-07-21 SG SG10201913618WA patent/SG10201913618WA/en unknown
- 2010-07-21 US US12/840,420 patent/US20110020292A1/en not_active Abandoned
- 2010-07-21 AU AU2010276264A patent/AU2010276264B2/en not_active Ceased
- 2010-07-21 EP EP10802822.6A patent/EP2456860B1/en active Active
-
2012
- 2012-01-19 IL IL217643A patent/IL217643B/en active IP Right Grant
-
2013
- 2013-11-01 US US14/070,075 patent/US20140134137A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2010276264B2 (en) | 2013-09-19 |
EP2456860A4 (en) | 2013-08-28 |
DK2456860T3 (en) | 2019-01-07 |
US20110020292A1 (en) | 2011-01-27 |
SG178065A1 (en) | 2012-03-29 |
US20140134137A1 (en) | 2014-05-15 |
CA2768573A1 (en) | 2011-01-27 |
WO2011011477A1 (en) | 2011-01-27 |
ES2690199T3 (en) | 2018-11-19 |
IL217643B (en) | 2018-03-29 |
SG10201404281YA (en) | 2014-09-26 |
CA2768573C (en) | 2020-09-15 |
EP2456860B1 (en) | 2018-09-05 |
EP2456860A1 (en) | 2012-05-30 |
AU2010276264A1 (en) | 2012-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL217648B (en) | Use of stem cells to reduce leukocyte extravasation | |
GB201213868D0 (en) | Improvements in or relating to methods of manufacture | |
GB201202848D0 (en) | Differemtiaiotn of human embryonic stem cells | |
IL223527B (en) | Generation of induced pluripotent stem cells from small volumes of peripheral blood | |
PL2494832T3 (en) | Scheduling of direct to direct communication | |
GB0902324D0 (en) | Improvements relating to valves | |
IL218996A0 (en) | Manipulation of osmolality for differentiating stem cells | |
GB201015271D0 (en) | Improvements relating to wheelchairs | |
SG10201404281YA (en) | Use of stem cells to reduce leukocyte extravasation | |
PL2411027T3 (en) | Use of a probiotic to regulate body weight | |
GB201011991D0 (en) | Improvements relating to valves | |
HRP20160818T1 (en) | Improvements to mechano-chemical reactors | |
GB0905189D0 (en) | Improvements relating to crutches | |
IL211567A0 (en) | Use of stem cells to prevent neuronal dieback | |
EP2383337A4 (en) | Novel promoter for use in transformation of algae | |
KR101027722B9 (en) | Purifier which is able to clean itself | |
EP2748329A4 (en) | Niche targeting of quiescent cancer stem cells | |
EP2654801A4 (en) | Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138 | |
HU0900810D0 (en) | Equipment to reduce gas consumption | |
GB201211721D0 (en) | Improvements is or relating to urolgical catheters | |
TWM370970U (en) | Improved structure of working table body | |
TWM372415U (en) | Improved structure of valve sets | |
PL390098A1 (en) | Use of essential oil to control mites | |
PL390096A1 (en) | Use of essential oil to control mites | |
GB201011738D0 (en) | Further improvements to chair arrangement |